27. Bull Cancer. 2018 Apr;105(4):415-425. doi: 10.1016/j.bulcan.2017.12.008. Epub2018 Feb 21.[Radiation therapy in inflammatory breast cancer].[Article in French]Jardel P(1), Alami Z(2), Vignot S(3), Creisson A(4), Danhier S(5), GeffrelotJ(5), Levy C(5), Kammerer E(5), Lebrun JF(6), Thariat J(7).Author information: (1)Centre intégré universitaire du Saguenay-Lac-Saint-Jean, service deradio-oncologie, 305, rue Saint-Vallier, G7H5H6 Chicoutimi, Québec, Canada.(2)Service de radiothérapie, CHU Hassan II, 30000 Fès, Maroc.(3)Institut médicale Jean-Godinot, service d'oncologie, avenue Koenig, 51100Reims, France.(4)Centre Antoine-Lacassagne, service d'oncologie, 33, avenue Valombrose, 06189Nice, France.(5)Centre de lutte contre le cancer François-Baclesse, service de radiothérapie, 3, avenue du Général-Harris, 14000 Caen, France.(6)Centre de lutte contre le cancer François-Baclesse, service de gynécologie et d'obstétrique, 3, avenue du Général-Harris, 14000 Caen, France.(7)Centre de lutte contre le cancer François-Baclesse, service de radiothérapie, 3, avenue du Général-Harris, 14000 Caen, France; Normandie université,laboratoire de physique corpusculaire, IN2P3/ENSICAEN, UMR6534, Unicaen,boulevard du Marechal-Juin, 14050 Caen, France. Electronic address:jthariat@gmail.com.BACKGROUND: Inflammatory breast cancer accounts for 1-5% of all breast cancers.It is associated with a poor prognosis, because of an increased risk to developmetastases in comparison with all breast malignancies. The treatment ismultimodal. We have evaluated the role of radiotherapy: indications, techniquesand impact for local control and overall survival.METHOD: The series of the literature with more than 40 patients irradiated forinflammatory breast cancer published since 1995 were analyzed.RESULTS: Chemotherapy was always delivered first. Adjuvant radiotherapy wasassociated with local control and overall survival at 10 years of 63-92% and51-64 respectively. Without surgery, local control was 65% and overal survival38% at 10years. Results of concomitant radiochemotherapy were reported: thestudies were heterogenous. Modalities of radiotherapy were detailed with respect to dose and fractionation, target-volumes and technical considerations (includingbolus).CONCLUSION: The multimodal strategy comprises systematically radiotherapy with anevaluation of tumor response to maximise resecability.Copyright © 2018 Société Française du Cancer. Published by Elsevier Masson SAS.All rights reserved.DOI: 10.1016/j.bulcan.2017.12.008 PMID: 29475596  [Indexed for MEDLINE]